Catalent is Up 22% Amidst Acquisition Rumors: Is the Stock Worth a Buy, Though?

By |2023-12-07T21:03:00+00:00February 6th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Catalent (CTLT) is all over the headlines this Monday morning as rumors surge of an acquisition. The buyer in question is Danaher (DHR), a company that designs and manufactures diagnostic tools for health, food, and water services. This play is said to be Danaher’s way of competing with Thermo Fisher Scientific. This marriage makes [...]